Collaboration with drug industry won’t affect clinical decisions, says new guideBMJ 2012; 344 doi: http://dx.doi.org/10.1136/bmj.e2489 (Published 02 April 2012) Cite this as: BMJ 2012;344:e2489
- Clare Dyer
Doctors are being urged not to be “tempted to accept the negative myths about cooperating with industry” in a new guide to promote collaboration between healthcare organisations and the drug industry to improve care of patients in the United Kingdom.
The guidance is supported by organisations representing the industry and by healthcare bodies including the BMA, the Academy of Medical Royal Colleges, and the royal colleges of GPs, physicians, and psychiatrists. The Department of Health for England, the NHS Confederation, and the governments of Scotland and Wales also back the guide, which is aimed at …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial